Circulating Tumor HPV DNA in Patients With Stage I and II HPV-Associated Head and Neck Cancer After Surgery-Reference-Cited by-同舟云学术

Circulating Tumor HPV DNA in Patients With Stage I and II HPV-Associated Head and Neck Cancer After Surgery

Published:2024-06-01 Issue:6 Volume:150 Page:521
ISSN:2168-6181
Container-title:JAMA Otolaryngology–Head & Neck Surgery
language:en
Short-container-title:JAMA Otolaryngol Head Neck Surg

Author:

Naegele Saskia¹²,Das Dipon¹²,Hirayama Shun¹²,Shalhout Sophia Z.¹²³,Lee Hang⁴,Richmon Jeremy D.¹²,Faden Daniel L.¹²⁵

Affiliation:

1. Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts

2. Massachusetts Eye and Ear, Boston

3. Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston

4. Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston

5. Broad Institute of MIT and Harvard, Cambridge, Massachusetts

Abstract

This cohort study examines the association of posttreatment circulating tumor human papillomavirus DNA (ctHPVDNA) with residual disease and 2-year overall survival and recurrence-free survival in patients with HPV-associated head and neck cancer.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamaotolaryngology/articlepdf/2818083/jamaotolaryngology_naegele_2024_ld_240004_1717443206.91446.pdf

Reference5 articles.

1. Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.;Cracchiolo;Cancer,2016

2. Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311).;Ferris;J Clin Oncol,2022

3. Cell-free HPV DNA provides an accurate and rapid diagnosis of HPV-associated head and neck cancer.;Siravegna;Clin Cancer Res,2022

4. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.;O’Boyle;Cancer,2022

5. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.;Guo;Cancer,2015